In recent studies, levels of biochemical markers such as complement factor H, Transthyretin6, complement factor B, alpha-1B-glycoprotein44, arylsulfatase A5, and apolipoprotein E45 were shown to be altered in maternal serum from women with DS-affected pregnancies. This evidence concerns the gene CFH and Dravet syndrome.